VIDEO: Unmet needs still exist in geographic atrophy management

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

There is still significant unmet needs in the management to geographic atrophy. Our newly approved therapeutic and others potentially coming again just slow the rate of growth. So for patients that already have symptoms or even decreased acuity, it’s not going to reverse it. And in fact, some visual dysfunction will continue to progress over time despite therapy. So we can certainly use more effective agents. None of these drugs are without their potential side effects, so improving upon the safety profile would also be something that would be considered another step forward. So more effective drugs to have a bigger impact on the rate of growth of geographic atrophy and ultimately also for our patients that have more advanced disease and have already suffered vision loss, the ability to improve the vision would be something very important that we hope to be able to achieve in the future.